메뉴 건너뛰기




Volumn 20, Issue 5, 2000, Pages 3169-3176

Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity

Author keywords

Anti invasion and NSCLC; Anti metastasis; TAC 101

Indexed keywords

4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDE]; 4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDO] BENZOIC ACID; BENZOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0033790267     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (14)

References (26)
  • 2
    • 0001163006 scopus 로고    scopus 로고
    • Non-small cell lung cancer, Charter 30
    • Cancer: principles and practice of oncology, 5th ed. (DeVita VT Jr., Hellman S and Rosenberg SA, eds). Philadelphia, PA., Lippincott-Raven
    • (1997) , pp. 858-911
    • Ginsberg, R.J.1    Vokes, E.E.2    Raben, A.3
  • 7
    • 0001319804 scopus 로고
    • Retinoid and human lung cancer
    • The Retinoids (Sporn MB, Roberts AB, Goodman DS, eds). New York, Raven Press
    • (1994) , pp. 597-658
    • Hong, W.K.1    Itri, L.M.2
  • 16
    • 0025859653 scopus 로고
    • Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents
    • (1991) Jpn J Cancer Chemother , vol.18 , pp. 1449-1456
    • Inaba, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.